Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2002 4
2003 2
2004 5
2005 4
2006 6
2007 5
2008 7
2009 9
2010 5
2011 4
2012 5
2013 5
2014 2
2015 7
2016 8
2017 12
2018 8
2019 9
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 12819245

102 results
Results by year
Filters applied: . Clear all
Page 1
Rituximab for idiopathic membranous nephropathy.
Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P. Remuzzi G, et al. Lancet. 2002 Sep 21;360(9337):923-4. doi: 10.1016/S0140-6736(02)11042-7. Lancet. 2002. PMID: 12354476 Clinical Trial.
Rituximab for idiopathic membranous nephropathy: who can benefit?
Ruggenenti P, Chiurchiu C, Abbate M, Perna A, Cravedi P, Bontempelli M, Remuzzi G. Ruggenenti P, et al. Clin J Am Soc Nephrol. 2006 Jul;1(4):738-48. doi: 10.2215/CJN.01080905. Epub 2006 Jun 14. Clin J Am Soc Nephrol. 2006. PMID: 17699281 Free article.
Rituximab in idiopathic membranous nephropathy.
Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Marasà M, Remuzzi G. Ruggenenti P, et al. J Am Soc Nephrol. 2012 Aug;23(8):1416-25. doi: 10.1681/ASN.2012020181. Epub 2012 Jul 19. J Am Soc Nephrol. 2012. PMID: 22822077 Free PMC article. Clinical Trial.
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group. Fervenza FC, et al. Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12. Nephron. 2015. PMID: 26087670 Clinical Trial.
Rituximab treatment of idiopathic membranous nephropathy.
Fervenza FC, Cosio FG, Erickson SB, Specks U, Herzenberg AM, Dillon JJ, Leung N, Cohen IM, Wochos DN, Bergstralh E, Hladunewich M, Cattran DC. Fervenza FC, et al. Kidney Int. 2008 Jan;73(1):117-25. doi: 10.1038/sj.ki.5002628. Epub 2007 Oct 17. Kidney Int. 2008. PMID: 17943078 Free article. Clinical Trial.
Latest treatment strategies for membranous nephropathy.
Ruggenenti P, Cravedi P, Remuzzi G. Ruggenenti P, et al. Expert Opin Pharmacother. 2007 Dec;8(18):3159-71. doi: 10.1517/14656566.8.18.3159. Expert Opin Pharmacother. 2007. PMID: 18035960 Review.
102 results